Cutamesine is primarily researched for its potential therapeutic applications in the field of neuroscience. It acts as a selective agonist for the sigma-1 receptor, which plays a role in modulating cellular signaling and neuroprotection. This makes it a candidate for treating neurological and psychiatric disorders, such as depression, anxiety, and cognitive impairments. Studies suggest it may help in enhancing memory and reducing stress-related symptoms. Additionally, its neuroprotective properties are being explored for conditions like Alzheimer’s disease and stroke. Cutamesine’s ability to stabilize cellular function under stress also makes it a subject of interest in research on neurodegenerative diseases.